Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04234113
Title Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sotio a.s.
Indications

Advanced Solid Tumor

Therapies

SO-C101

Pembrolizumab + SO-C101

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.